Withdrawn Trial Highlights Growing Interest in AI-Supervised Exercise Programs for Knee Osteoarthritis Management

References

1. 1.Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., ... & Wolfe, F. (1986). Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis & Rheumatism, 29(8), 1039-1049. https://doi.org/10.1002/art.1780290816
2. 2.Australian Institute of Health and Welfare. (2023). Osteoarthritis in Australia (PHE 321). AIHW. https://www.aihw.gov.au/reports/chronic-musculoskeletal-conditions/osteoarthritis
3. 3.Bellamy, N., Buchanan, W. W., Goldsmith, C. H., Campbell, J., & Stitt, L. W. (1988). Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. Journal of Rheumatology, 15(12), 1833-1840.
4. 4.Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., ... & Reston, J. (2020). 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care & Research, 72(2), 149-162. https://doi.org/10.1002/acr.24131
5. 5.Pisters, M. F., Veenhof, C., Schellevis, F. G., Twisk, J. W., Dekker, J., & De Bakker, D. H. (2010). Exercise adherence improving long-term patient outcome in patients with osteoarthritis of the hip and/or knee. Arthritis Care & Research, 62(8), 1087-1094. https://doi.org/10.1002/acr.20182
6. 6.Therapeutic Goods Administration. (2023). Software as a Medical Device (SaMD): Guidance for industry. TGA. https://www.tga.gov.au/resources/resource/guidance/software-medical-device-samd-guidance-industry
7. 7.Uludag University. (2024). Effectiveness of Exercises Supervised Via an Artificial Intelligence-Supported Mobile Application in Patients With Knee Osteoarthritis. ClinicalTrials.gov. NCT07066514. https://clinicaltrials.gov/study/NCT07066514